Clinical Trials Browser

Phase 1 × C04.588.274.476.411.307 × Clear all

NCT05070104 2023-09-13

CPI-613 (Devimistat) in Combination With Modified FOLFIRINOX Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Phase 1 Withdrawn

C04.588.274.476.411.307